InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Breber Sandra, Chief Executive Officer. Director active across 2 companies, notably Augmedix, Inc.. Cumulatively, 2 disclosures have been published. Total volume traded: €86k. The latest transaction was disclosed on 28 October 2021 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
€42,79512,500 shares@ €3.4236100.0% of flow
Common Stock
SEC:0001213900-21-055926·
Ideal exit: 25 Jul 2022 (T+270)
€42,79512,500 shares@ €3.423650.0% of flow
Common Stock
SEC:0001213900-21-055926:0·
Ideal exit: 25 Jul 2022 (T+270)
2 of 2 declarations
About Breber Sandra
Sandra Breber is the Chief Operating Officer at Augmedix, Inc. She is responsible for managing operations and implementing growth strategies. Her role is essential for ensuring the company's efficiency and profitability.
